Annual CAPEX
$836.00 K
-$2.04 M-70.89%
30 April 2024
Summary:
Champions Oncology annual capital expenditures is currently $836.00 thousand, with the most recent change of -$2.04 million (-70.89%) on 30 April 2024. During the last 3 years, it has fallen by -$2.44 million (-74.52%). CSBR annual CAPEX is now -74.52% below its all-time high of $3.28 million, reached on 30 April 2021.CSBR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
31 July 2024
Summary:
Champions Oncology quarterly capital expenditures is not available.CSBR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
31 July 2024
Summary:
Champions Oncology TTM capital expenditures is not available.CSBR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.9% | - | - |
| 3 y3 years | -74.5% | - | - |
| 5 y5 years | +0.2% | - | - |
CSBR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | at low | ||||
| 5 y | 5 years | -74.5% | +0.2% | ||||
| alltime | all time | -74.5% | >+9999.0% |
Champions Oncology CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2024 | $836.00 K(-70.9%) | -$111.00 K(-188.1%) | $836.00 K(-51.0%) |
| Jan 2024 | - | $126.00 K(-17.6%) | $1.71 M(-26.9%) |
| Oct 2023 | - | $153.00 K(-77.1%) | $2.33 M(-16.2%) |
| July 2023 | - | $668.00 K(-12.1%) | $2.79 M(-3.0%) |
| Apr 2023 | $2.87 M(+20.5%) | $760.00 K(+0.8%) | $2.87 M(+9.7%) |
| Jan 2023 | - | $754.00 K(+24.8%) | $2.62 M(+15.4%) |
| Oct 2022 | - | $604.00 K(-19.9%) | $2.27 M(+1.7%) |
| July 2022 | - | $754.00 K(+49.0%) | $2.23 M(-6.4%) |
| Apr 2022 | $2.38 M(-27.3%) | $506.00 K(+24.9%) | $2.38 M(-12.7%) |
| Jan 2022 | - | $405.00 K(-28.4%) | $2.73 M(-22.6%) |
| Oct 2021 | - | $566.00 K(-37.6%) | $3.53 M(+1.7%) |
| July 2021 | - | $907.00 K(+6.2%) | $3.47 M(+5.8%) |
| Apr 2021 | $3.28 M(+47.8%) | $854.00 K(-29.0%) | $3.28 M(-17.0%) |
| Jan 2021 | - | $1.20 M(+137.7%) | $3.95 M(+35.3%) |
| Oct 2020 | - | $506.00 K(-29.5%) | $2.92 M(+33.5%) |
| July 2020 | - | $718.00 K(-53.0%) | $2.19 M(-1.4%) |
| Apr 2020 | $2.22 M(+166.2%) | $1.53 M(+793.0%) | $2.22 M(+166.2%) |
| Jan 2020 | - | $171.00 K(-175.3%) | $834.00 K(-4.1%) |
| Oct 2019 | - | -$227.00 K(-130.3%) | $870.00 K(-36.6%) |
| July 2019 | - | $749.00 K(+431.2%) | $1.37 M(+64.5%) |
| Apr 2019 | $834.00 K(-32.1%) | $141.00 K(-31.9%) | $834.00 K(-7.8%) |
| Jan 2019 | - | $207.00 K(-24.7%) | $905.00 K(+17.1%) |
| Oct 2018 | - | $275.00 K(+30.3%) | $773.00 K(+45.8%) |
| July 2018 | - | $211.00 K(-0.5%) | $530.00 K(-56.9%) |
| Apr 2018 | $1.23 M(+60.4%) | $212.00 K(+182.7%) | $1.23 M(-23.3%) |
| Jan 2018 | - | $75.00 K(+134.4%) | $1.60 M(-4.5%) |
| Oct 2017 | - | $32.00 K(-96.5%) | $1.68 M(+1.1%) |
| July 2017 | - | $910.00 K(+55.6%) | $1.66 M(+116.6%) |
| Apr 2017 | $766.00 K(+137.9%) | $585.00 K(+287.4%) | $766.00 K(+134.3%) |
| Jan 2017 | - | $151.00 K(+1061.5%) | $327.00 K(+6.2%) |
| Oct 2016 | - | $13.00 K(-23.5%) | $308.00 K(-0.6%) |
| July 2016 | - | $17.00 K(-88.4%) | $310.00 K(-3.7%) |
| Apr 2016 | $322.00 K(+170.6%) | $146.00 K(+10.6%) | $322.00 K(+52.6%) |
| Jan 2016 | - | $132.00 K(+780.0%) | $211.00 K(+129.3%) |
| Oct 2015 | - | $15.00 K(-48.3%) | $92.00 K(-20.0%) |
| July 2015 | - | $29.00 K(-17.1%) | $115.00 K(-3.4%) |
| Apr 2015 | $119.00 K(-49.1%) | $35.00 K(+169.2%) | $119.00 K(-22.7%) |
| Jan 2015 | - | $13.00 K(-65.8%) | $154.00 K(-32.8%) |
| Oct 2014 | - | $38.00 K(+15.2%) | $229.00 K(+0.9%) |
| July 2014 | - | $33.00 K(-52.9%) | $227.00 K(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2014 | $234.00 K(+310.5%) | $70.00 K(-20.5%) | $234.00 K(+25.8%) |
| Jan 2014 | - | $88.00 K(+144.4%) | $186.00 K(+77.1%) |
| Oct 2013 | - | $36.00 K(-10.0%) | $105.00 K(+34.6%) |
| July 2013 | - | $40.00 K(+81.8%) | $78.00 K(+36.8%) |
| Apr 2013 | $57.00 K(-89.0%) | $22.00 K(+214.3%) | $57.00 K(-68.9%) |
| Jan 2013 | - | $7000.00(-22.2%) | $183.00 K(-52.7%) |
| Oct 2012 | - | $9000.00(-52.6%) | $387.00 K(-12.6%) |
| July 2012 | - | $19.00 K(-87.2%) | $443.00 K(-14.6%) |
| Apr 2012 | $519.00 K(+510.6%) | $148.00 K(-29.9%) | $519.00 K(+26.9%) |
| Jan 2012 | - | $211.00 K(+224.6%) | $409.00 K(+85.9%) |
| Oct 2011 | - | $65.00 K(-31.6%) | $220.00 K(+37.5%) |
| July 2011 | - | $95.00 K(+150.0%) | $160.00 K(+88.2%) |
| Apr 2011 | $85.00 K(+1.2%) | $38.00 K(+72.7%) | $85.00 K(-6.6%) |
| Jan 2011 | - | $22.00 K(+340.0%) | $91.00 K(+18.2%) |
| Oct 2010 | - | $5000.00(-75.0%) | $77.00 K(+28.3%) |
| July 2010 | - | $20.00 K(-54.5%) | $60.00 K(-28.6%) |
| Apr 2010 | $84.00 K(-33.3%) | $44.00 K(+450.0%) | $84.00 K(-34.4%) |
| Jan 2010 | - | $8000.00(-166.7%) | $128.00 K(-14.0%) |
| Oct 2009 | - | -$12.00 K(-127.3%) | $148.90 K(-4.6%) |
| July 2009 | - | $44.00 K(-50.0%) | $156.00 K(+23.8%) |
| Apr 2009 | $126.00 K(+168.1%) | $88.00 K(+204.5%) | $126.00 K(+231.6%) |
| Jan 2009 | - | $28.90 K(-689.8%) | $38.00 K(+317.6%) |
| Oct 2008 | - | -$4900.00(-135.0%) | $9100.00(-35.0%) |
| July 2008 | - | $14.00 K(>+9900.0%) | $14.00 K(+382.8%) |
| Apr 2008 | $47.00 K(+1520.7%) | - | - |
| Apr 2004 | $2900.00(-68.1%) | $0.00(0.0%) | $2900.00(+163.6%) |
| Jan 2004 | - | $0.00(0.0%) | $1100.00(-57.7%) |
| Oct 2003 | - | $0.00(-100.0%) | $2600.00(-61.2%) |
| July 2003 | - | $2900.00(-261.1%) | $6700.00(-26.4%) |
| Apr 2003 | $9100.00(-36.8%) | -$1800.00(-220.0%) | $9100.00(-49.4%) |
| Jan 2003 | - | $1500.00(-63.4%) | $18.00 K(-22.4%) |
| Oct 2002 | - | $4100.00(-22.6%) | $23.20 K(+17.8%) |
| July 2002 | - | $5300.00(-25.4%) | $19.70 K(+36.8%) |
| Apr 2002 | $14.40 K(-57.3%) | $7100.00(+6.0%) | $14.40 K(+97.3%) |
| Jan 2002 | - | $6700.00(+1016.7%) | $7300.00(-2.7%) |
| Oct 2001 | - | $600.00(>+9900.0%) | $7500.00(-77.7%) |
| Apr 2001 | $33.70 K(+149.6%) | $0.00(-100.0%) | $33.70 K(0.0%) |
| Jan 2001 | - | $6900.00(-40.5%) | $33.70 K(+25.7%) |
| Oct 2000 | - | $11.60 K(-23.7%) | $26.80 K(+76.3%) |
| July 2000 | - | $15.20 K | $15.20 K |
| Apr 2000 | $13.50 K | - | - |
FAQ
- What is Champions Oncology annual capital expenditures?
- What is the all time high annual CAPEX for Champions Oncology?
- What is Champions Oncology annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Champions Oncology?
- What is the all time high TTM CAPEX for Champions Oncology?
What is Champions Oncology annual capital expenditures?
The current annual CAPEX of CSBR is $836.00 K
What is the all time high annual CAPEX for Champions Oncology?
Champions Oncology all-time high annual capital expenditures is $3.28 M
What is Champions Oncology annual CAPEX year-on-year change?
Over the past year, CSBR annual capital expenditures has changed by -$2.04 M (-70.89%)
What is the all time high quarterly CAPEX for Champions Oncology?
Champions Oncology all-time high quarterly capital expenditures is $1.53 M
What is the all time high TTM CAPEX for Champions Oncology?
Champions Oncology all-time high TTM capital expenditures is $3.95 M